NCT06971276View on ClinicalTrials.gov

Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening

RecruitingOBSERVATIONAL

Enrollment

101

Participants

Timeline

Start Date

April 3, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Anal Dysplasia

Trial Locations (1)

02114

RECRUITING

Department of Infectious Diseases, Mass General Hospital, Boston

All Listed Sponsors

lead

Massachusetts Eye and Ear Infirmary

OTHER